Wells Fargo & Company Amphastar Pharmaceuticals, Inc. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
282Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$274 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$123 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$98.4 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$89.6 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$74.8 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.26B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...